Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPM8 channel associated factor 2 (TCAF2) is an accessory protein that directly binds to the TRPM8 channel, a non-selective cation channel with roles in thermosensation and prostate cancer[1][4]. TCAF2 helps recruit TRPM8 to the plasma membrane and promotes prostate cancer cell migration. It has an opposing function to its close paralog TCAF1, which inhibits cancer cell migration and supports TRPM8 activity. TCAF2 is not a typical therapeutic target itself but is part of the regulatory machinery of the TRPM8 channel, which is a validated drug target in cancer and other diseases[1][4]. The encoded protein is primarily found in the plasma membrane and cell junctions, plays a regulatory role, and may contribute to cancer progression[4]. If you seek information on a classical drug target, consider TRPM8 itself (Transient receptor potential melastatin 8) rather than TCAF2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRPM8 channel associated factor 2 (TCAF2).